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Summary
TGFb presented and activated by integrin avb6
expressed on alveolar epithelial cells (AEC) continu-
ously inhibits the functionality of alveolar macro-
phages (AM). Despite this inhibition, AM retain their
ability to respond to inhaled microorganisms. Herein
we describe a homeostatic circuit through which the
effects of microbial products on macrophages tran-
siently circumvent this inhibition by repressing avb6
expression on AEC. Subsequent production of matrix
metalloproteinases by activated AM activates latent
TGFb, reinduces avb6 expression, and thereby rein-
states tonic inhibition of AM function. Our results
reveal how AM can be activated while minimizing their
potential to inflict collateral damage to the adjacent
lung tissue and indicate that tissue-specific micro-
environmental factors shape organ-specific defense
strategies against microbial invasion.
Introduction
Previous investigations have documented an immuno-
suppressive microenvironment within the normal lung
(Bingisser and Holt, 2001; Munger et al., 1999). Indeed,
different studies have indicated that AM are inefficient
in providing accessory cell-like activity compared to
macrophages from other tissues. In fact, AM have
been shown to suppress dendritic and T and B cell func-
tions most likely via the secretion of NO, PGE2, IL-10, or
TGFb (Lipscomb et al., 1993; Thepen et al., 1994).
TGFb is a pleiotropic cytokine that modulates a variety
of biological processes such as cell growth, apoptosis,
extracellular matrix synthesis, inflammation, and im-
mune responses (Fitzpatrick and Bielefeldt-Ohmann,
1999; Shi and Massague, 2003). Mature TGFb is se-
creted in a complex with its N-terminal fragment, the
latency-associated peptide (LAP), which inhibits its
function. Latent TGFb is activated extracellularly by pro-
teolytic cleavage or by interaction with thrombospondin
or with specific integrins including avb6 (Annes et al.,
2003).
Integrins are dimeric cell-surface receptors com-
posed of a and b subunits (Hynes, 2002; van der Flier
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Aand Sonnenberg, 2001). A recent study has demon-
strated that the epithelial integrin, avb6, binds to TGFb
LAP and activates TGFb (Munger et al., 1999). Subse-
quently, the activated TGFb binds to its receptors on
AM or fibroblasts and leads to the continuous suppres-
sion of AM functionality. Mice lacking the avb6 integrin
have spontaneously activated AM, and reexpression of
the integrin in a subset of alveolar epithelial cells sup-
presses this macrophage activation (Morris et al., 2003).
The respiratory tract is exposed constantly to inhaled
particles and microorganisms that are usually cleared
by a coordinated movement of the mucocilliary epithe-
lium in the upper airways and by AM in the alveolar
space. As the major sentinel of innate immunity in the
alveolar space, AM should be capable of responding ap-
propriately to inhaled microorganisms. The mechanism
by which AM perform this task in the presence of contin-
uous and tonic inhibition by TGFb is still unclear. Our re-
sults presented below describe a homeostatic circuit in
which microbial compounds initiate and then suppress
AM activity via complex interactions with AEC involving
the regulation of integrin avb6 expression.
Results
TLR Ligands Suppress Integrin avb6 Expression
in the Lung
The family of Toll-like receptors (TLR) is one of the main
microbial sensing systems of innate immunity (Krutzik
and Modlin, 2004; Takeda et al., 2003). By interacting
with a variety of signature microbial compounds, TLR
initiate inflammatory and protective responses in the
host. To evaluate the effect of TLR ligands on the ex-
pression of integrin avb6, we initially injected an immu-
nostimulatory oligonucleotide (ISS-ODN, also known
as CpG-ODN, a TLR9 ligand) i.v. into C57Bl/6 mice.
The lungs were harvested, and the kinetics of mRNA
and protein expression of integrin av and b6 subunits
was analyzed. While the mRNA levels of TGFb1 were un-
changed, those of integrin av and b6 subunits were pro-
foundly diminished as measured by RT-PCR (Figure 1A)
as well as concordant protein levels as measured by im-
munoblot (Figure 1B). Next, to confirm that this gene
suppression of integrin av and b6 is not restricted to
ISS-ODN, other TLR ligands were also tested. All other
TLR ligands tested showed a similar profile (Figure 1C),
demonstrating that this phenomenon applies to at least
those TLR ligands tested. In initial experiments, ISS-
ODN was i.v. injected into mice; however, in reality
TLR ligands enter the lung from the outside environ-
ment. To simulate by a more natural route, ISS-ODN
was intratracheally (i.t.) administered, and this i.t. ad-
ministration resulted in the same inhibition of integrin
avb6 (Figure 1D).
Despite i.v. administration of ISS-ODN that systemi-
cally distributed the compound throughout the entire
body, the inhibition of integrin avb6 was a lung-specific
event, as other organs analyzed did not display this in-
hibitory effect (Figure 1E).
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476Figure 1. TLR Ligands Suppress Integrin avb6 Expression in the Lung Tissue
(A) ISS-ODN (TLR9 ligand) suppresses the transcript levels of integrin avb6 in lung tissue. ISS-ODN (20 mg/mouse) was i.v. injected into C57Bl/6
(B6) mice. Transcript levels of TGFb1, integrin av (ITGav), and integrin b6 (ITGb6) were analyzed by RT-PCR.
(B) ISS-ODN inhibits protein expression of integrin avb6 in lung tissue. B6 mice were i.v. injected with ISS-ODN (20 mg/mouse) and lung tissue
homogenates were prepared. The integrin avb6 was immunoprecipitated with anti-avb6 monoclonal ab (10D5) and then immunoblotted with
anti-integrin av polyclonal abs.
(C) Different TLR ligands suppress the transcription of integrin b6 in lung tissue. B6 mice were i.v injected with the following TLR ligands:
Pam3Cys (50 mg, TLR2), poly (I:C) (50 mg, TLR3), LPS (10 mg, TLR4), flagellin (50 mg, TLR5), or R848 (20 mg, TLR7). The transcript levels of integrin
b6 (ITGb6) in lung tissue were analyzed by RT-PCR 24 hr later.
(D) Comparison of intratracheal (i.t.) to i.v. injection. ISS-ODN was administrated into B6 mice via i.v. injection (20 mg/mouse) or i.t. instillation
(2 mg/mouse). The mRNA levels of integrin b6 (ITGb6) and integrin av (ITGav) in lung tissue were analyzed by qPCR 24 hr later. *p < 0.02 between
ISS-injected to noninjected groups.
(E) Tissue-specific suppression of integrin b6 by ISS-ODN. B6 mice were i.v. injected with ISS-ODN (20 mg/mouse). The transcript levels of
integrin b6 in the various tissues were analyzed by RT-PCR.
The data are shown as the mean 6 SD and are representative of two or more experiments.
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to Downregulation of TGFb Signaling
The genetic deletion of integrin b6 resulted in a defect in
TGFb activation and the consequent activation of AM
(Morris et al., 2003). If integrin avb6 is in fact a key acti-
vator of latent TGFb in the lung, suppression of integrin
avb6 should lead to the downregulation of the basal
phosphorylation level of Smad2/3. Thus, we hypothe-
sized that the administration of TLR ligands might also
inhibit TGFb signaling. Indeed, the levels of pSmad2/3
were reduced in the lung lysates and in AM (Figure 2A)
after ISS-ODN administration. However, this effect of
ISS-ODN administration was not observed in mice in
which the human integrin b6 is continuously expressed
in the lung tissue (Figure 2B).
In Vivo Administration of ISS-ODN Increases
the Responsiveness of AM to LPS In Vitro
The data presented thus far suggested that after
ISS-ODN administration, AM are released from TGFb-
mediated suppression. To test this prediction, we mea-
sured and compared the responsiveness of both AM
and peritoneal macrophages (PM) isolated from naive
mice and from mice pretreated with ISS-ODN to subse-
quent LPS (TLR4 ligand) stimulation in vitro. The tran-
script levels of TNFa and IL-6 were measured by
RE
TRqPCR. AM isolated from ISS-pretreated mice displayedhigher levels of these transcripts than AM from naivemice, in contrast to PM that displayed a mRNA profilethat is consistent with endotoxin tolerance (Figures 2Cand 2D) (Dobrovolskaia et al., 2003). However, this effectof ISS-ODN pretreatment on subsequent LPS stimula-
tion in vitro was not observed in mice in which the
human integrin b6 is continuously expressed in the
lung tissue (Figure 2E).
AM Initiate the Inhibition of Integrin
avb Expression on AEC
We next explored the mechanisms by which TLR signal-
ing suppressed the expression of integrin avb6 subunits
by using bone marrow (BM) chimeric mice. In control ir-
radiated wt recipient mice that were reconstituted with
wt BM, administration of ISS-ODN successfully dimin-
ished the transcription level of integrin b6 compared to
that observed for TLR92/2 recipients that received wt
BM. In contrast, the administration of ISS-ODN failed
to reduce integrin b6 levels in chimeric mice that had
TLR92/2 BM in wt recipients and TLR92/2 BM in
TLR92/2 recipients (Figure 3A). Additionally, in TLR92/2
mice that had their resident AM depleted by i.n. delivery
of clodronate liposomes (resulting in a 70%–90% deple-
tion of resident AM 48 hr after liposome delivery), only
Induction of a Homeostatic Circuit in the Lung
477Figure 2. Suppression of Integrin avb6 Expression Is Linked to Downregulation of TGFb Signaling
(A) ISS-ODN suppresses TGFb signaling. B6 mice were i.v. injected with ISS-ODN (20 mg per mouse). At 24 hr postinjection, homogenates of lung
tissue or of AM were prepared. Smad 2/3 was immunoprecipitated with anti-Smad 2/3 abs and then immunoblotted with anti-pSmad2/3 abs.
(B) ISS-ODN fails to suppress the TGFb signaling in hITGb6 transgenic mice. Human ITGb6 transgenic mice (B6) in which the human ITGb6 gene is
constitutively expressed under the h-surfactant protein C promoter were i.v. injected with ISS-ODN (20 mg/mouse). At 24 hr postinjection,
homogenates of lung tissue were prepared and the levels of pSmad2/3 were measured as described above.
(C and D) In vivo administration of ISS-ODN increases the responsiveness of AM (C) but not PM (D) to a subsequent in vitro LPS stimulation. AM
and PM were isolated from naive or from ISS-injected mice (20 mg/mouse) 24 hr postinjection. The cells (23 105/well) were then stimulated with
LPS (10 ng/ml) for 2 hr. The transcript levels of TNFa and IL-6 were analyzed by qPCR.
(E) In hITGb6 transgenic mice, the injection of ISS-ODN fails to increase the responsiveness of AM to a subsequent in vitro LPS stimulation. AM
were isolated from naive or ISS-injected hITGb6 transgenic mice (20 mg/mouse) 24 hr postinjection. The cells (23 105/well) were then stimulated
with LPS (10 ng/ml) for 2 hr. The transcript levels of TNFa and IL-6 were analyzed by qPCR.
The data are shown as the mean 6 SD and are representative of two or more experiments.
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Dadoptively transferred wt AM and not TLR92/2 AM
showed a reduction in integrin b6 transcription levels
24 hr after i.v. administration of ISS-ODN (Figure 3B).
Furthermore, direct stimulation of an AEC line (MLE12)
with ISS-ODN did not inhibit the expression of integrin
avb6 (data not shown). Taken together, these results in-
dicate that AM are the cells that respond to TLR ligands
and initiate the subsequent inhibition of integrin avb6
expression on AEC (Figures 3A and 3B).
We then evaluated whether a soluble factor secreted
by TLR9-activated hematopoietic cells inhibits integrin
avb6 expression. We injected ISS-ODN to IFNa/bR2/2,
IFNg2/2, IL-102/2, COX22/2, IL-12p402/2, and TNFa2/2
mice (i.e., TLR9-induced genes). As presented in Fig-
ure 3C, the administration of ISS-ODN to each of these
mutant mice suppressed b6 transcript levels in the lung
RE similar to wt mice. To further explore the potential contri-bution of other soluble factors secreted by TLR9-activated cells, we prepared conditioned medium (CM)from a single-cell suspension prepared from wild-typewhole lung or spleen that was stimulated in vitro with
ISS-ODN. The intraperitoneal (i.p.) injection of lung CM
to wt and to TLR9-deficient mice failed to suppress the
expression levels of integrin avb6, suggesting that a
TLR9-induced soluble factor did not mediate the ob-
served inhibition of integrin avb6 (Figure 3D). Similar re-
sults were obtained upon i.p. injection with spleen CM
(data not shown). Although a role for a short-lived soluble
mediator cannot be excluded and the specific hemato-
poietic cell(s) activated by TLR ligands are still unidenti-
fied, these results favor a cognate interaction between
AM and AEC.
Immunity
478Figure 3. AM Initiate the Inhibition of Integrin
avb6 Expression on AEC
(A) TLR9 in BM cells dictates the inhibition of
integrin avb6 on AEC by ISS-ODN. Four sets
of wt/TLR9 bone marrow (BM) chimeric
mice were generated. Mice were injected
i.v. with ISS-ODN (20 mg/mouse), the lung tis-
sues were harvested 24 hr later, and the
levels of integrin b6 were analyzed by qPCR
in lung homogenates. Lane 1, wt recipients
that received wt BM; lane 2, wt recipients
that received TLR92/2 BM; lane 3, TLR92/2
recipients that received wt BM; lane 4,
TLR92/2 recipients that receivedTLR92/2BM.
(B) AM dictates the inhibition of integrin avb6
on AEC by ISS-ODN. Resident AM were
depleted in TLR92/2 mice by clodronate lipo-
somes delivered i.n. to the lung. AM were iso-
lated from either wt or TLR92/2mice and then
intratracheally transferred (2 3 106 per
mouse) to recipient TLR92/2 mice 48 hr after
the delivery of the liposomes. 24 hr later,
mice were i.v. injected with 20 mg ISS-ODN.
After another 24 hr, the lungs were harvested
and levels of integrin b6 measured in lung ho-
mogenates by qPCR. The data represent one
out of two experiments.
(C) TLR9-induced cytokines do not mediate
the suppression of integrin b6 by ISS-ODN.
ISS-ODN (20 mg/mouse) was i.v. injected to
IFNa/bR2/2, IFNg2/2, IL12p402/2, TNFa2/2,
IL102/2, and COX22/2 mice. The transcript
levels of integrin b6 in lung homogenates
were analyzed by qPCR 24 hr later. *p < 0.02
between ISS-injected and noninjected
groups.
(D) In vivo injection of conditioned medium
prepared from lung cells treated with ISS-
ODN failed to suppress gene transcription of
integrin avb6. Conditioned media was pre-
pared by treatment of a single cell suspension
of lung tissue (B6 mice) with ISS-ODN (10 mg/
ml) for 24 hr. Thereafter, conditioned media
was intraperitoneally injected into B6 mice
or TLR92/2 mice. The transcript levels of in-
tegrin avb6 in lung tissue were analyzed by
qPCR 24 hr later.
The data are shown as the mean 6 SD and
are representative of two or more experi-
ments.TR
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between AM and AEC
As TGFb was previously proposed to induce integrin
avb6 expression (Zambruno et al., 1995), we evaluated
its regulatory role in our system. The incubation of two
different AEC lines (MLE12 and MLE15) with active
TGFb resulted in the increase of gene expression levels
of integrin av, integrin b6, TbRI (TGFb receptor I), and
TbRII (TGFb receptor II) (Figure 4A and data not shown
for MLE15). Coculture of primary AM with the AEC line,
MLE12, induced the expression of integrin b6 on AEC,
and the administration of anti-TGFb ab inhibited this in-
duction (Figure 4B). The physical association between
the AM and AEC was mandatory for this process since
the coincubation of AM and AEC in a bichamber system
that prevented cell-to-cell contact did not induce the ex-
pression of integrin b6 on AEC. To further identify the na-
ture of the cognate interaction between AM and AEC
RE that drives the expression of integrin b6 on AEC, wetreated AM with anti-integrin av ab prior to their cocul-ture with AEC. The anti-integrin av ab blocked the induc-tion of integrin b6 on AEC (Figure 4B). Taken together,these data suggest that physical association betweenthe AM and AEC enhances TGFb production and thatintegrin av expressed on AM with TGFb are required
to trigger integrin b6 expression on AEC.
To further establish the potential involvement of TGFb
in the regulation of integrin avb6 expression on AEC, ac-
tive TGFb was coinjected with ISS-ODN to wt mice. In-
deed, the administration of active TGFb blocked the
suppression of integrin b6 transcription induced by
ISS-ODN (Figure 4C) and inhibited the LPS-induced
TNFa and IL-6 transcript levels in AM in vitro (Figure 4D).
As TGFb induces its own receptors (Figure 4A), the
reduction in integrin avb6 levels on AEC (Figure 1A)
is also expected to inhibit the expression of these
Induction of a Homeostatic Circuit in the Lung
479Figure 4. TGFb Is an Intermediate in the Cognate Interaction between Primary Isolated AM and AEC
(A) TGFb induces gene induction of integrin av and b6 and TGF receptor-I and -II (TbRI and II). A mAEC line, MLE12, was incubated with 10 ng/ml
of recombinant active TGFb. AEC were harvested, and the transcription levels of integrin av and b6 as well as TbRI and II were analyzed by qPCR
as indicated. *p < 0.01 in comparison to the 0 hr levels in each group.
(B) Coculture of AEC with primary AM induces the expression of TGFb-dependent ITGb6 gene transcription. MLE12 was bi- or cocultured with
AM in absence or presence of 10 mg/ml anti-TGFb antibody. Lane 1, MLE12 alone; lane 2, MLE12 + AM (biculture); lane 3, MLE12 + AM (coculture);
lane 4, MLE12 + AM (coculture) + anti-TGFb ab; lane 5, MLE12 + AM (coculture) + anti-av ab; lane 6, MLE12 + AM (coculture) + control ab. Similar
results were obtained for the expression of TbRI and TbRII on AEC (data not shown).
(C) Exogenous TGFb overcomes the suppression of ITGb6 gene transcription caused by ISS-ODN in lung tissue. Active TGFbwas coinjected with
ISS-ODN to B6 mice. The levels of integrin b6 were analyzed by qPCR 24 hr later. Lane 1, naive; lane 2, ISS-ODN (20 mg/mouse); lane 3, ISS-ODN
with TGFb (5 ng/mouse); lane 4, ISS-ODN with TGFb (50 ng/mouse); lane 5, TGFb (50 ng/mouse).
(D) Administration of active TGFb blocks the increase in AM responsiveness to a subsequent in vitro LPS stimulation. Active TGFb (50 ng/mouse)
was coinjected with ISS-ODN (20 mg/mouse) to B6 mice. 24 hr postinjection, AM were stimulated with LPS (10 ng/ml) for 2 hr, and the transcript
levels of TNFa and IL-6 were analyzed by qPCR.
(E) Kinetics of TbRI and TbRII transcript levels in AM after ISS-ODN administration. ISS-ODN was i.v. injected into B6 mice (20 mg/mouse) and the
transcription levels of TbRI and II in the isolated AM were analyzed by qPCR. *p < 0.02 in comparison to the 0 hr levels.
The data are shown as the mean 6 SD and are representative of two or more experiments.RE
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EDreceptors on AM. As presented in Figure 4E, the inhibi-
tion of the TGFbRI and TGFbRII gene expression fol-
lowed by ISS-ODN administration on AM matched the
kinetics of avb6 protein expression on AEC (Figure 1B).
Thus, although the regulation of integrin avb6 expres-
sion by another soluble factor was not ruled out above,
we favor a model in which TGFb associated with AM in
their quiescent state most likely control the expression
of integrin avb6 in AEC. The proposed model of this
interaction is presented below.Actin Polymerization in AM Controls the Expression
of Integrin avb6 on AEC
In subsequent studies, we analyzed the kinetics of the
above observed inhibition of integrin avb6. Our initial re-
sults demonstrated that the suppression of integrin avb6
in vivo started within the first 30 min post-ISS-ODN ad-
ministration (data not shown). One event that occurs
rapidly and is triggered in TLR-activated cells is actin
polymerization (Hayashi et al., 2003). Indeed, we ob-
served rapid actin polymerization in AM and in an AM
Immunity
480Figure 5. Actin Polymerization in AM Controls the Expression of Integrin avb6 on AEC
(A) ISS-ODN induces actin polymerization in AM. AM were isolated from the lung of naive B6 mice and were stimulated with fMLP (1027 M) or
ISS-ODN (1 mg/ml) and then stained with FITC-labeled phalloidin, and the fluorescent intensity was measured by FACS (105 cells per time point)
at the indicated time points.
(B) Microbial products induce actin polymerization in a mAM line (MH-S). MH-S cells were stimulated with LPS, ISS-ODN, and fMLP as above and
actin polymerization was determined at appropriate time points by staining with rhodamine-labeled phalloidin followed by visualization under
a fluorescent microscope (203 magnification).
(C) Kinetics of integrin b6 transcript levels after ISS-ODN administration. ISS-ODN was i.v. injected into B6 mice (20 mg/mouse), and the levels of
integrin b6 in lung tissue were analyzed by qPCR and plotted.
(D) Kinetics of TGFb signaling after ISS-ODN administration. ISS-ODN was i.v. injected into B6 mice (20 mg/mouse) and the phosphorylation
levels of Smad 2/3 in the lung tissue were measured as described above.
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481cell line (MH-S) stimulated not only with a control stimu-
lator fMLP, but also with TLR4 and TLR9 ligands with
a response time of approximately 10 min (Figures 5A
and 5B). A minimal response time for the suppression
of integrin avb6 gene expression by ISS-ODN was
once again carefully measured and was shown to start
less than 10 min postadministration (Figure 5C). The
same time period was identified to inhibit TGFb signaling
in the lung tissue in ISS-ODN-injected mice (Figure 5D).
Formyl-MLP (fMLP) is a non-TLR ligand, bacterial pep-
tide that binds to a G protein-coupled receptor (McCoy
et al., 1995). Surprisingly, fMLP administration also
suppresses the expression of integrin avb6 on AEC
(Figure 5E) and inhibits subsequent TGFb signaling in
AM (Figure 5F).
The data above suggested that actin polymerization in
AM is likely the key event that controls integrin avb6 ex-
pression on AEC. To address this issue, we evaluated
the effects of an inducer and an inhibitor of actin poly-
merization in our system. Indeed, jasplakinolide (in-
ducer) (O’Reilly et al., 2003) suppressed integrin b6 ex-
pression whereas latrunculin-A (inhibitor) (DeFife et al.,
1999) reversed the inhibition of this gene induced by
ISS-ODN (Figure 5G). As actin polymerization is involved
in endocytosis and its inhibition may therefore affect
ISS-ODN uptake and consequently the inhibition of
TLR9 signaling, we evaluated the induction of ISS-
induced TNFa in this system to exclude this possibility.
As presented in Figure 5H, TNFa was induced by ISS-
ODN in the presence of latrunculin-A, demonstrating
that endocytosis was not affected by this compound.
Collectively, these results indicate the pivotal role of
actin polymerization in AM in the control of integrin
avb6 expression on AEC.
ISS-Induced MMP9 Restores TGFb Inhibitory
Effects on AM
Our previous data demonstrated that microbial com-
pounds released AM from TGFb-mediated suppression;
however, it was still unclear whether this process is re-
versible. To explore this issue, we initially checked the
kinetics of integrin avb6 and the pSmad2/3 levels in
the lung tissue after ISS-ODN administration. As shown
in Figure 6A, integrin avb6 expression was profoundly
inhibited only in the first 2 days post-ISS-ODN adminis-
tration. We observed similar kinetics for pSmad2/3 (Fig-
ure 6B). As MMPs are involved in the activation of vari-
ous enzymes and growth factors (Mott and Werb,
2004), we postulated that an ISS-induced MMP could
reactivate latent TGFb. Thus, we initially identified the
induction profile of various MMPs in the lung tissue after
i.v. ISS-ODN administration. MMP3, MMP8, MMP9,
MMP12, and MMP13, but not MMP2, transcripts were
induced (Figure 6C). As MMP9 was the only MMP in-
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Aduced within the first 2 days that is also known to acti-
vate the latent TGFb complex (Yu and Stamenkovic,
2000), we hypothesized that this MMP might, therefore,
end the cycle of microbial ligand-induced AM activation.
To explore the potential role of MMP9 in restoring the
TGFb-mediated suppression on AM, we checked its en-
zymatic activity (Figure 6D) in the lung tissue after ISS-
ODN administration. In preliminary studies, we identified
that ISS-induced IFNg mediates MMP9 expression. In-
deed, the administration of ISS-ODN to IFNgR2/2 mice
failed to induce MMP9 (Figure 6E). Consequently, we
observed a prolonged suppression of both integrin b6
levels in the lung tissue (Figure 6E) and TGFb signaling
in AM (Figure 6F) in these mice. To further establish
the cause and effect relationship between MMP9 enzy-
matic activity, TGFb signaling, and integrin b6 expres-
sion, we administrated ISS-ODN in MMP92/2 mice. In-
deed, in these mice the kinetics of suppression of
integrin b6 expression (Figure 6G) and TGFb signaling
(Figure 6H) were prolonged. Taken together, these
data indicate that the subsequent ISS-induced produc-
tion of MMP9 by AM activates latent TGFb, reinduces
avb6 expression on AEC, and thereby reinstates tonic
inhibition of AM. The proposed role of this pathway is
presented schematically below.
Phagocytic and Bactericidal Activities
of AM Post ISS Administration
We demonstrated the transient effects of ISS-ODN on
the inhibition of integrin avb6 and the phosphorylation
levels of Smad2/3 (Figures 6A and 6B). To explore
whether the transient release of AM from TGFb-medi-
ated suppression affects the phagocytic and bacteri-
cidal activities of AM, we isolated these cells from
mice at different time periods post ISS-ODN injection
and measured their responsiveness to subsequent in vi-
tro LPS stimulation. As shown in Figure 7A, AM isolated
from mice treated with ISS-ODN for 1 and 2 days prior to
in vitro restimulation with LPS produced higher levels of
IL-6 and TNFa as compared to AM isolated from naive,
nonmanipulated mice (day 0). In contrast, PM isolated
from these mice produced very low levels of these cyto-
kines (Figure 7B).
Based on the results displayed in Figure 7A, we iso-
lated AM from mice 1 and 3 days post ISS injection. As
predicted, the phagocytic and bactericidal activities of
AM isolated 1 day, but not 3 days, post ISS injection
were significantly higher upon in vitro infection with
Klebsiella pneumoniae (Figures 7C and 7D). While PM
isolated from the same mice displayed high phagocytic
and bactericidal activities, there were no major changes
in these activities in PM isolated from mice injected with
ISS-ODN either 1 or 3 days prior to bacterial infection
in vitro (data not shown).
C
ED(E) fMLP suppresses the transcript levels of integrin av and b6 in lung tissue. fMLP (5 mg/mouse) was i.v. injected into B6 mice. The transcript
levels were analyzed by qPCR and compared to those obtained for ISS-ODN (20 mg/mouse). *p < 0.04 compared to noninjected group.
(F) fMLP suppresses the TGFb signaling in AM. fMLP (5 mg/mouse) was i.v. injected to B6 mice. At 24 hr postinjection, AM were isolated and
pSmad 2/3 levels were analyzed and compared to those obtained for ISS-ODN (20 mg/mouse) as described above.
(G) Actin polymerization controls the suppression of integrin b6 gene expression. ISS-ODN (20 mg/mouse), the actin polymerization inducer jas-
plakinolide (5 mg/mouse), the actin polymerization inhibitor latrunculin-A (20 mg/mouse), or a combination of latrunculin A and ISS-ODN were i.v.
injected to B6 mice. The transcript level of ITGb6 was analyzed by qPCR 2 hr postinjection in lung homogenates.
(H) Latrunculin-A does not block the induction of TNFa by ISS-ODN. The transcript levels of TNFa were measured in the lung homogenates (see
above) and analyzed by qPCR.
The data are shown as the mean 6 SD and are representative of two or more experiments.
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482Figure 6. ISS-Induced MMP9 Restores TGFb Inhibitory Effects on AM
(A) Duration of the suppression of the transcript levels of integrin av and b6. B6 mice were i.v. injected with ISS-ODN (20 mg/mouse). The transcript
levels of ITGav and b6 and of TGFb were measured by RT-PCR in lung homogenates. IDO (indolamine 2,3-dioxygenase) transcript levels were
used as positive control.
(B) Kinetics of inhibition of TGFb signaling induced by ISS-ODN. B6 mice were i.v. injected with ISS-ODN (20 mg/mouse), and the pSmad2/3 levels
were measured in lung homogenates as described above.
(C) ISS-ODN induces gene transcription of MMPs. B6 mice were i.v. injected with ISS-ODN (20 mg/mouse), and the levels of MMP2, MMP3,
MMP8, MMP9, MMP12, and MMP13 were measured by RT-PCR.
(D) ISS-ODN induces MMP9 but not MMP2 gelatinase enzymatic activity. B6 mice were i.v. injected with ISS-ODN, and the enzymatic activity of
MMP2 and MMP9 in the lung homogenates was measured by zymography (gelatin gel).
(E) ISS-ODN-induced IFNg mediates MMP9 transcription. IFNgR2/2 mice were i.v. injected with ISS-ODN (20 mg/mouse), and the transcription
levels of ITGb6 and MMP9 were measured in lung homogenates by RT-PCR.
(F) Kinetics of TGFb signaling in ISS-ODN-injected IFNgR2/2 mice. IFNgR2/2 mice were i.v. injected with ISS-ODN (20 mg/mouse), and the
pSmad2/3 levels were measured in AM homogenates by Western blotting.
(G) In MMP92/2mice, suppression of ITGb6 transcript levels by ISS-ODN lasts longer than in wt mice. MMP92/2mice were i.v. injected with ISS-
ODN (20 mg/mouse) and the transcript levels of ITGb6 was measured by RT-PCR.
(H) In MMP92/2 mice, suppression of TGFb signaling by ISS-ODN lasts longer than in wt mice. MMP92/2 mice were i.v. injected with ISS-ODN
(20 mg/mouse), and the pSmad2/3 levels were measured in AM homogenates by Western blotting.
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483Figure 7. Phagocytic and Bactericidal Activi-
ties of AM Post-ISS Administration
(A and B) AM (A) and PM (B) were isolated at
different time periods after i.v. ISS-ODN in-
jection (20 mg/mouse) as described. The cells
were then stimulated in vitro with LPS (10 ng/
ml) for 2 hr. The transcript levels of TNFa and
IL-6 were analyzed by qPCR.
(C and D) AM isolated from mice 1 but not
3 days after ISS-ODN injection display en-
hanced phagocytosis and bactericidal activ-
ities upon in vitro infection with Klebsiella
pneumoniae.
The data are shown as the mean 6 SD and
are representative of two or more experi-
ments.
ED
Discussion
AM are positioned to sample and respond to micropar-
ticles and microorganisms that enter the alveolar space.
TGFb, via its unique association with AEC bound integrin
avb6, inhibits AM functionality under quiescent condi-
tions. In contrast, other factors such as NO, PGE2, and
IL-10 inhibit AM responses only after these factors
have been induced (Bingisser and Holt, 2001). This
inhibitory milieu could impede the innate immune re-
sponse of AM to inhaled microorganisms and conse-
quently make the lung vulnerable to multiple airborne
microbial agents unless there is a mechanism that al-
lows a rapid response. Our study provides the mecha-
nisms for this quick and complex adaptation.
The administration of TLR ligands suppressed the
basal TGFb crosstalk between AM-AEC and the sub-
sequent expression of integrin avb6 (but not of TGFb)
by AEC. As a result, AM were released from TGFb-medi-
ated immunosuppression and mounted a higher cyto-
kine response to a subsequent TLR stimulation (Figures
2 and 7). The data in Figures 3 and 4 indicate that (1) AM
initiate the suppression of integrin avb6 on nonhemato-
poietic cells, i.e., AEC, (2) this inhibition is mediated via
an AM-AEC, cell-cell interaction, and (3) membrane
bound TGFb is involved in this process.
The rapid inhibition of integrin avb6 suggests that the
AM-AEC, cell-cell interaction was disrupted (Figure 5).
This disruption can be mediated through actin polymer-
ization that modifies the cell shape of TLR-activated AM.
Actin polymerization could also lock integrins on the
macrophages into an inactive, low-affinity conformation
(Kinbara et al., 2003). It also decreases the elasticity of
the activated cell (e.g., AM) and consequently interferes
with its interactions with neighboring cells (e.g., AEC)
(Figure 8B) (Giannone et al., 2004). We confirmed the
involvement of actin polymerization in our system by
using fMLP and jasplakinolide (inducers of actin poly-
merization). Both agents activated actin polymerization
R
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on AM, which resulted in the inhibition of integrin avb6
expression on AEC (Figure 5), whereas latrunculin A
(an inhibitor of actin-polymerization) blocked the
TLR9-induced inhibition of integrin avb6 (Figure 5).
An uncontrolled activation of AM can induce collateral
damage in the lung tissue that could lead to organ dys-
function (Morris et al., 2003). Indeed, our data indicate
that integrin avb6 expression (AEC) and TGFb signaling
(AM) are recovered within 2–3 days poststimulation (Fig-
ure 6). We also identified that the administration of TLR9
ligand induced MMP9 transcript and enzymatic activity
in the lung via IFNg secretion (Figure 6). As latent TGFb
is one of the substrates of MMP9, we speculated that
MMP9 could turn off AM activation. Indeed, the admin-
istration of TLR9 ligand to IFNgR2/2 mice resulted in
prolonged inhibition of integrin b6 expression (AEC)
and TGFb signaling (AM). Similar results were obtained
when TLR9 ligand was injected to MMP9-deficient
mice (Figure 6) or coinjected with MMP9 inhibitor to wt
mice (data not shown), indicating that TLR-triggered
MMP9, through activation of TGFb, resets this system
to its quiescent phase (Figure 8D). Furthermore, the
phagocytic and bactericidal activities of AM isolated 1
day, but not 3 days, post ISS-ODN injection were signif-
icantly higher upon in vitro infection with Klebsiella
pneumoniae, confirming the transient nature of AM acti-
vation (Figure 7).
Our results illustrate a unique crosstalk between AM
and AEC. They describe a novel mechanism that is initi-
ated by different classes of microbial products but with
different and distinct signaling pathways (TLR ligands,
fMLP) that activate and consequently inactivate innate
immunity (i.e., AM) in the alveolar space. We describe
this activation-inactivation cycle of innate immunity elic-
ited by microbial products as a homeostatic circuit
(Figure 8). The tight control of AM explains how AM
can be activated by microbial products or respond to
microbial agents in the alveolar space while minimizing
their ability to inflict structural injury and functional
CT
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484Figure 8. Proposed Scheme of the Homeostatic Circuit
Microbial products activate and inactivate AM through an intricate communication with AEC.
(A) Tonic inhibition of AM by TGFb presented by integrin avb6 on AEC in the steady state. When microbial products enter the alveolar space, they
are recognized by innate immune receptors on AM. This recognition results in a cell shape change in AM due to actin polymerization. Actin
polymerization disrupts the TGFb signaling of AEC initiated by AM (bx = unidentified integrin b-chain) and leads to the disengagement of AM
from AEC.
(B) This disengagement impairs the production of TGFb by AEC and AM and is soon followed by a reduction of TGFb signaling in both AEC and
AM. The basal protein expression of integrin avb6 on AEC is no longer maintained. A reduction in the protein levels of integrin avb6 on AEC (4–8 hr)
results in impaired TGFb activation of AM.
(C) Subsequent inhibition of TGFb signaling releases AM from the tonic suppression by TGFb.
(D) After 48 hr, AM produce MMP9 that activates latent TGFb. The active TGFb then binds to its receptors on both AM and AEC, reinduces integrin
avb6 and avbx expression, and subsequently reinstates the tonic inhibition of AM observed in the steady state.
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Ddamage to the adjacent lung tissue. Furthermore, these
results underscore the concept of organ-specific innate
immunity and propose that in addition to the unique
biochemical characteristics of a variety of signature
microbial products (e.g., TLR ligands), tissue-specific
microenvironmental factors are also involved in shaping
organ-specific defense strategies against microbial in-
vasion. Finally, on a practical level, our data provide
the insight to expand the activation phase of innate
immunity in the lung, a process that can be utilized to
reduce the risk of illness due to any airborne microbial
agent (Figure 7), including those that can be used for
bioterrorism purposes.
Experimental Procedures
Reagents
We used the following abs: monoclonal anti-mouse integrin avb6
(10D5), anti-mouse integrin av for Western blotting (Chemicon, Te-
mecula, CA), anti-mouse integrin av chain (anti-mouse CD51, BD
Pharmingen, San Diego, CA), and anti-TGFb1-3 (1D11, R&D
Systems, Inc., Minneapolis, MN) for blocking in cocultures, anti-
Smad2/3 (Santa Cruz Biotechnology, Santa Cruz, CA), and anti-
phospho Smad2/3 (Cell Signaling Technology, Beverly, MA). The
sources of TLR ligands were mentioned elsewhere (Hayashi et al.,
2003). Flagellin was kindly provided by Dr. J.A. Didonato (Cleveland
Clinic Foundation, Cleveland, OH). fMLP, Jasplakinolide, and
Latrunculin were purchased from Calbiochem (San Diego, CA).
Recombinant active TGFb1 was purchased from PeproTech, Inc
(Rocky Hill, NJ). The mouse pulmonary epithelial cell lines, MLE12
and MLE15, and mouse AM cell line, MH-S, were purchased from
American Type Culture Collection (Rockville, MD). Mouse TGFb
ELISA was performed with a DuoSet ELISA kit purchased from
R&D Systems.
Mice
Female C57Bl/6 (B6) wild-type mice, 5–6 weeks of age, and cyto-
kine-deficient mice, i.e., IFNg2/2, IL-12p402/2 IL-102/2, COX22/2,
ET
Rand TNFa2/2 (B6), were purchased from The Jackson Laboratory
(Bar Harbor, ME). IFNa/bR2/2 mice (129) were purchased from
B&K Universal (East Yorkshire, UK). TLR9-deficient (B6) mice were
obtained from Dr. S. Akira (Osaka University, Osaka, Japan) and
bred at the University of California, San Diego (San Diego, CA). Hu-
man (h) ITGb6 transgenic mice (B6) were generated and bred at the
University of California, San Francisco (Huang et al., 1998). MMP9
mice and their wild-type controls (FVB) were purchase from The
Jackson Laboratory.
Generation and Validation of Bone Marrow Chimeric Mice
TLR92/2/wt chimeric mice were generated as described (Cho et al.,
2002). On the day of transfer, the recipient mice received whole body
irradiation with 1000 rad from a 137 Cs source at the Irradiation Fa-
cility, UCSD. Bone marrow cells were harvested from the femurs of
the donor mice (TLR92/2 or wt mice) and resuspended in RPMI-1640
media without FCS, and 10 3 106 bone marrow cells were i.v. in-
jected into irradiated recipient mice. Four groups of chimeras were
created: wt to wt, wt to TLR92/2, TLR92/2 to wt, and TLR92/2 to
TLR92/2. The recipient mice were continued on antibiotics for 6
weeks after bone marrow transfer to minimize the risk of inadvertent
infections. 6 weeks after transfer, the recipient mice were screened
for % of chimerism by qPCR. Primers used for wt allele are 50-AGG
AAG GTT CTG GGC TCA AT-30 and 50-TCT GTA CCC CGT TTC TCT
GC-30 that yield a 200 bp product. Primers used for KO allele are
50-TCT GTA CCC CGT TTC TCT GC-30 and 50-ATC GCC TTC TAT
CGC CTT CTT GAC GAG-30 that yield a 220 bp product. A standard
curve was created via blood mixtures of wt and TLR92/2mice in var-
ious ratios. The percentage of wt or TLR92/2 DNA in the chimeras
was then calculated by this standard curve. Mice demonstrating
>90% chimerisms were used in experiments.
Transfer of Primary Isolated AM after Depletion
of Resident AM in Donor Mice
AM depletion in mice was achieved by intranasal (i.n.) administration
of a total of 120 ml of a liposome-encapsulated clodronate suspen-
sion (Vrije Universiteit, Amsterdam, The Netherlands). Under light
anesthesia, 40 ml of liposomes was i.n. delivered to TLR92/2 mice,
three times in 1 day, 2 hr apart. This procedure depleted w70%–
90% of resident AM as determined by total macrophage counts
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485identified by morphology in the bronchoalveolar lavage fluid 48 hr af-
ter liposome delivery. AM for transfer were prepared from either wt
(C57BL/6) or TLR92/2 donor mice by bronchoalveolar lavage by
means of cold PBS containing 1 mM EDTA. 2 3 106 wt or TLR92/2
AM were delivered intratracheally to the lungs of TLR92/2 recipient
mice that had received clodronate liposomes 48 hr previously.
Infection of Alveolar Macrophages with
Klebsiella pneumoniae In Vitro
Alveolar macrophages were harvested by bronchoalveolar lavage,
resuspended in RPMI supplemented with 10% fetal bovine serum,
seeded into 48-well plates at a density of 3 3 105 cells/well, and
allowed to adhere for 90 min at 37ºC in a 5% CO2 incubator. Assays
of bacterial phagocytosis and intracellular survival were modified
from previously described procedures (Browne et al., 2002; Libby
et al., 2000). The inoculum consisted of Klebsiella pneumoniae
ATCC strain 43816 (Deng et al., 2004), grown to stationary phase
in LB medium (Chen et al., 1995). The bacteria were diluted 1:5
(vol/vol) with LB, washed once with Dulbecco’s phosphate-buffered
saline (DPBS), resuspended in DPBS, mixed 1:1 (vol/vol) with fresh
heparinized mouse plasma, and incubated at 37ºC for 20 min. The
opsonized bacteria were diluted in DPBS and used to inoculate
the macrophage cultures at a ratio of 20 bacteria per macrophage.
The infected cultures were centrifuged at 200 3 g for 5 min to bring
the bacteria in contact with the macrophages, then incubated 45 min
at 37ºC. The medium was removed and replaced with fresh RPMI
containing 10% fetal bovine serum and gentamicin at 20 mg/ml to
kill extracellular bacteria. The initial number of intracellular bacteria
(phagocytosis assay) was determined by incubation for an addi-
tional 45 min at 37ºC, removal of the culture media, lysis of macro-
phages by the addition of 0.5% deoxycholate in DPBS, and detec-
tion of bacterial colony-forming units (CFU) by serial dilution and
plating on LB agar. Intracellular survival was determined by incuba-
tion of infected cultures for 24 hr after addition of the gentamicin me-
dium, followed by harvest and detection of CFU as described above.
Survival was expressed as the CFU remaining after 24 hr/initial CFU
after phagocytosis.
Semiquantitative RT-PCR and Real-Time RT-PCR
Total RNA was prepared from tissue or from culture cells by means
of TRIzol reagent according to the manufacturer’s instructions (Invi-
trogen, Carlsbad, CA). Total RNA (3–5 mg) was subjected to reverse
transcription with the Super Script II Reverse Transcriptase and re-
action conditions specified by the manufacturer (Invitrogen). The
transcript of target genes was then determined with a semiquantita-
tive one-step RT-PCR with b-actin as an internal control. PCR was
carried out under the following conditions: 94ºC, 1 min; 68ºC,
2 min for each cycle, and the PCR products were separated on
a 1.4% agarose gel and visualized by ethidium bromide staining.
Expression of target genes was normalized to that of b-actin. The
RT-PCR primers specific for target genes were designed based on
their reported sequences, using the Primer 3 program (primer3_
www.cgi v 0.1 b 1a) and synthesized by IDT Technologies (Caralville,
IA). Primer sequences can be found in the Supplemental Data avail-
able with this article online. For quantitation of the transcription level
of target genes, cDNA samples were further analyzed by real-time
PCR with TaqMan Universal PCR Master Mix (Applied Biosystems,
Foster City, CA).
Immunoprecipitation
Immunoprecipitation was performed by standard methodologies.
Lung tissue or AM were homogenized in lysis buffer (10 mM HEPES
[pH 7.9], 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1% Triton X-100, 1
mM glycerophosphate, 2.5 mM sodium pyrophosphate, 1 mM so-
dium orthovanadate) containing protease inhibitor cocktails
(Sigma). 100 mg of each of lung crude extract was mixed with primary
antibody (2 mg/ml) and incubated at 4ºC with constant mixing for
12 hr. For immunoprecipitation of integrin avb6 and Smad 2/3, the
samples were mixed with mouse monoclonal antibody against in-
tegrin avb6 (10D5) (Chemicon) and with goat polyclonal antibody
against Smad 2/3 (Santa Cruz Biotechnology), respectively. The im-
munocomplex was captured by the addition of packed protein A
crosslinked 4% beaded agarose (Calbiochem) (50 ml/500 ml superna-
tant) for 2 hr at 4ºC. Beads were washed three times with lysis buffer.
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analysis as described below.
Immunoblot/Western Analysis
Beads with immunocomplexes were resuspended in loading buffer,
heated at 95ºC for 3 min, and elecrophoresed on 10%–20% Tricine
SDS-PAGE (Invitrogen). After electrophoresis, the proteins were
transferred onto PVDF membrane in a buffer containing 25 mM
Tris-Hcl (pH 8.3)/192 mM glycine/20% methanol and blocked with
TBST (50 mM Tris-HCl [pH 7.5]/150 mM NaCl/0.1% Tween 20) con-
taining 2% of bovine serum albumin for at least 1 hr. The blots were
washed three times with TBST and then incubated overnight with
primary antibody. For detection of integrin avb6 and phosphorylated
Smad 2/3, the blots were incubated with rabbit polyclonal anti-
bodies against integrin av (Chemicon) or against phospho-Smad
2/3 (Cell Signaling Technology), respectively. The blots were sub-
sequently washed three times with TBST and incubated with horse-
radish peroxidase-conjugated anti-rabbit IgG secondary antibody
(Pierce). Proteins were visualized by ECL detection system (Amer-
sham Biosciences) according to the manufacturer’s instruction.
In Vitro Stimulation of AM with LPS
Primary AM were obtained from naive or from ISS-ODN
(20 mg/mouse)-treated C57BL/6 mice (24 hr postadministration) by
bronchoalveolar lavage (BAL) using sterile PBS containing 1 mM
EDTA. AM were plated in 24-well plate at 1 3 105 cells/well in final
volume of 1 ml RPMI-1640 medium (BioWhittaker, Walkersville,
MD) supplemented with 10% heat-inactivated fetal bovine serum.
When indicated, cells were stimulated with LPS (10 ng/ml) for 2 hr.
ISS-Induced Conditioned Media
Conditioned media were prepared from a single-cell suspension of
lung tissue or spleen of C57BL/6 mice that were stimulated with
10 mg/ml ISS-ODN for 48 hr. Conditioned media from unstimulated
lung cells or spleen cells were used as a control. C57BL/6 mice or
TLR92/2 mice (nonresponsive to ISS-ODN) were intraperitoneally
(i.p.) injected with 1 ml of ISS-conditioned media or control media
and then sacrificed 24 hr postinjection. Lungs were harvested and
analyzed for transcription level of integrin avb6.
In Vitro Bi- or Coculture of AM with Epithelial Cells
MLE12 cells (AEC) were grown in HITES medium (RPMI-1640
supplemented with insulin, transferrin, sodium selenite [Sigma,
St. Louis, MO], 10 mM hydrocortisone [Sigma], 10 mM b-estradiol
[Sigma], HEPES [Sigma], penicillin/streptomycin [Sigma], and 2%
heat-inactivated fetal calf serum) in 24- or 48-well plates until conflu-
ent. AM were isolated by BAL from B6 mice.
In some experiments, a portion of primary isolated AM were pre-
treated with 10 mg/ml anti-TGFb ab (R&D Systems) for 1 hr at 37ºC.
10 mg/ml of this antibody is reported by the manufacturer to neutral-
ize up to 25 ng TGFb/ml. Without washing out the antibody in order
to neutralize any further TGFb secreted by AEC, 0.6 3 105 AM were
added to wells containing confluent AEC ( = coculture). In some ex-
periments, a portion of freshly isolated AM were pretreated with
20 mg/ml anti-integrin av ab (BD Pharmingen) for 1 hr at 37ºC. The
AM were then washed twice to remove the antibody before adding
to wells containing AEC.
Other experiments used AM added to wells either with ( = bicul-
ture) or without ( = coculture) a transwell insert (0.4 mM, Corning,
Inc., Corning, NY), which physically separated the AM from coming
into direct contact with AEC. All co- and biculture experiments were
then incubated overnight at 37ºC (24 hr).
Detection of MMP2 and MMP9 by Zymography
Proteolytic activity of MMP-2 and MMP-9 was analyzed by zymo-
graphy as described (Martinez-Torres et al., 2004). Lung tissue
crude extracts in loading buffer were loaded on 10% polyacrylamide
gels (Invitrogen) containing 0.1% gelatin. After electrophoresis, the
gels were incubated in 50 mM Tris-HCl (pH 7.5) containing 0.2 M
NaCl, 5 mM CaCl2, and 2.5% Triton X-100 for 30–60 min and subse-
quently incubated overnight at room temperature in the same buffer
without Triton X-100. The gels were then stained with Coomassie
blue (0.25% Coomassie blue, 10% methanol, and 10% glacial acetic
acid) and destained in the same solution without dye.
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F-actin content in macrophages activated by LPS or ISS-ODN was
assessed by flow cytometry (Kutsuna et al., 2004) or by fluorescent
microscopy.
Forflowcytometryexperiments,AM(B6)or themurinecell lineMH-S
(ATCC) were stimulated with ISS-ODN (final 1 mg/ml) or LPS (final
10 ng/ml) for 5, 10, or 20 min in polypropylene tubes. The cells were
then fixed, permeabilized, and stained with FITC-phalloidin in a single
step with the addition of a solution of formaldehyde and saponin
(Fix/Perm,BDPharmingen)containing5ng/mlFITC-phalliodin (Sigma)
for 15 min at room temperature in the dark. The cells were washed with
PBS containing saponin and subjected to flow cytometry.
For fluorescent microscopy experiments, AM (MH-S cell line) were
seeded onto chamber slides overnight. ISS-ODN (1 mg/ml), LPS
(10 ng/ml), fMLP (1027 M), or media were added for various times,
and the cells were fixed and permeabilized before the addition of
rhodamine-labeled phalloidin for 15 min at room temperature. The
slides were washed and coverslips added before being examined
microscopically.
Statistical Analysis
Data are expressed as mean 6 standard deviation. Statistical anal-
ysis was performed according to the Student’s t test for unpaired
data. p < 0.05 was considered significant.
Supplemental Data
Supplemental Experimental Procedures can be found with this
article online at http://www.immunity.com/cgi/content/full/24/4/
475/DC1/.
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